|
US4767842A
(en)
|
1973-05-07 |
1988-08-30 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US5698201A
(en)
|
1973-05-07 |
1997-12-16 |
The Ohio State University |
Method for treatment of antigenically modified polypeptides
|
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
US4483793A
(en)
|
1982-10-04 |
1984-11-20 |
The Regents Of The University Of California |
Dimeric oligopeptides as heptenic epitopic sites for hepatitis
|
|
US4782137A
(en)
|
1984-01-24 |
1988-11-01 |
Immunex Corporation |
Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same
|
|
US4703004A
(en)
|
1984-01-24 |
1987-10-27 |
Immunex Corporation |
Synthesis of protein with an identification peptide
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5175385A
(en)
|
1987-09-03 |
1992-12-29 |
Ohio University/Edison Animal Biotechnolgy Center |
Virus-resistant transgenic mice
|
|
GB8727045D0
(en)
|
1987-11-19 |
1987-12-23 |
Research Corp Ltd |
Immunoglobulin e competitor
|
|
AU618317B2
(en)
|
1987-12-31 |
1991-12-19 |
Tanox Biosystems, Inc. |
Unique antigenic epitopes on ige-bearing b lymphocytes
|
|
US5254671A
(en)
*
|
1990-04-27 |
1993-10-19 |
Tanox Biosystems, Inc. |
Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
|
|
WO1989007142A1
(en)
|
1988-02-05 |
1989-08-10 |
Morrison Sherie L |
Domain-modified constant region antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
GB8910263D0
(en)
|
1989-05-04 |
1989-06-21 |
Ciba Geigy Ag |
Monoclonal antibodies specific for an immunoglobulin isotype
|
|
GB8913737D0
(en)
|
1989-06-15 |
1989-08-02 |
Univ Birmingham |
A novel anti-allergy treatment
|
|
US5955076A
(en)
|
1989-06-15 |
1999-09-21 |
Peptide Therapeutics Limited |
Immunoactive peptides and antibodies and their use in anti-allergy treatment
|
|
KR920703114A
(ko)
|
1989-07-14 |
1992-12-17 |
원본미기재 |
접합체 백신을 위한 시토킨 및 호르몬 운반체
|
|
US5733553A
(en)
|
1989-09-29 |
1998-03-31 |
Talwar; Gursaran Prasad |
Recombinant birth control vaccine
|
|
CA2074089C
(en)
|
1990-01-23 |
2001-04-10 |
Tse-Wen Chang |
Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
|
|
CA2082529A1
(en)
|
1990-05-25 |
1991-11-26 |
Denis R. Stanworth |
Immunodiagnostic assay for rheumatoid arthritis
|
|
US5196197A
(en)
|
1990-08-29 |
1993-03-23 |
National Institute Of Immunology |
Reversible fertility control for prevention of pregnancy in females
|
|
CA2097291A1
(en)
*
|
1990-12-13 |
1992-06-14 |
David P. Gearing |
Leukemia inhibitory factor receptors
|
|
SE9102808L
(sv)
|
1991-09-26 |
1993-03-27 |
Lars T Hellman Inst F Immunolo |
Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
|
|
US5837686A
(en)
|
1991-11-25 |
1998-11-17 |
Peptide Therapeutics Limited |
Peptides and antibodies for treatment of rheumatoid arthritis
|
|
WO1994005698A1
(en)
|
1992-09-01 |
1994-03-17 |
United Nations Industrial Development Organization |
Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum
|
|
AU5361794A
(en)
|
1992-10-14 |
1994-05-09 |
Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
|
|
US5762931A
(en)
|
1992-12-31 |
1998-06-09 |
National Institute Of Immunology |
Anti-cancer utility of HCG vaccines
|
|
US5532142A
(en)
*
|
1993-02-12 |
1996-07-02 |
Board Of Regents, The University Of Texas System |
Method of isolation and purification of fusion polypeptides
|
|
US5552537A
(en)
*
|
1993-03-24 |
1996-09-03 |
The Regents Of The University Of California |
IgE isoforms and methods of use
|
|
US5501855A
(en)
|
1993-09-02 |
1996-03-26 |
Talwar; Gursaran P. |
Neem oil as a male contraceptive
|
|
DK96493D0
(da)
|
1993-08-26 |
1993-08-26 |
Mouritsen Og Elsner Aps |
Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
|
|
US5874085A
(en)
|
1993-11-10 |
1999-02-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Vaccine for enhanced production of IgA antibodies
|
|
FR2715304B1
(fr)
|
1994-01-26 |
1996-04-26 |
Merieux Serums Vaccins Pasteur |
Vaccin anti-allergique.
|
|
AU2195395A
(en)
|
1994-03-28 |
1995-10-17 |
United Biomedical Inc. |
Synthetic peptide based immunogens for the treatment of allergy
|
|
US5651981A
(en)
*
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
|
AU4012095A
(en)
|
1994-10-25 |
1996-05-15 |
United Biomedical Inc. |
Synthetic ige membrane anchor peptide immunogens for the treatment of allergy
|
|
GB9422294D0
(en)
|
1994-11-04 |
1994-12-21 |
Peptide Therapeutics Ltd |
Peptides for anti-allergy treatment
|
|
US6949244B1
(en)
|
1995-12-20 |
2005-09-27 |
The Board Of Trustees Of The University Of Kentucky |
Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
|
|
JPH08333390A
(ja)
|
1995-04-07 |
1996-12-17 |
Hoechst Japan Ltd |
ペプチド及びそれからなる自己免疫疾患治療剤
|
|
US6034066A
(en)
|
1995-07-17 |
2000-03-07 |
Peptide Therapeutics Limited |
Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
|
|
ZA966075B
(en)
|
1995-07-27 |
1998-01-19 |
Genentech Inc |
Protein formulation.
|
|
US5723125A
(en)
*
|
1995-12-28 |
1998-03-03 |
Tanox Biosystems, Inc. |
Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
|
|
CA2245497C
(en)
|
1996-03-01 |
2009-02-24 |
Novartis Ag |
Peptide immunogens for vaccination against and treatment of allergy
|
|
EP0917570A2
(en)
|
1996-08-05 |
1999-05-26 |
The President And Fellows Of Harvard College |
Mhc binding peptide oligomers and methods of use
|
|
CN1178955C
(zh)
|
1997-04-15 |
2004-12-08 |
法默卡有限公司 |
经修饰的TNFα分子和编码该TNFα分子的DNA以及含有该TNFα分子和该DNA的疫苗
|
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
US5891432A
(en)
*
|
1997-07-29 |
1999-04-06 |
The Immune Response Corporation |
Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
|
|
AU1145699A
(en)
|
1997-09-05 |
1999-03-22 |
Smithkline Beecham Biologicals (Sa) |
Oil in water emulsions containing saponins
|
|
AU3291099A
(en)
|
1998-02-11 |
1999-08-30 |
Maxygen, Inc. |
Genetic vaccine vector engineering
|
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
|
TWI227241B
(en)
|
1998-06-20 |
2005-02-01 |
United Biomedical Inc |
IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
|
|
SK4272001A3
(en)
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
MXPA01005389A
(es)
|
1998-11-30 |
2003-03-27 |
Cytos Biotechnology Ag |
Presentacion molecular ordenada de antigenos, metodos de preparacion y uso.
|
|
GB9908533D0
(en)
|
1999-04-14 |
1999-06-09 |
Novartis Ag |
Organic compounds
|
|
HUP0200958A3
(en)
|
1999-04-23 |
2004-11-29 |
Pharmexa As |
Method for down-regulating il5 activity
|
|
AU7658101A
(en)
|
2000-07-28 |
2002-02-13 |
Cytos Biotechnology Ag |
Compositions for inducing self-specific anti-ige antibodies and uses thereof
|
|
IL154219A0
(en)
|
2000-09-06 |
2003-07-31 |
Pharmexa As |
Method for down-regulating ige
|
|
JP2004537991A
(ja)
|
2001-06-15 |
2004-12-24 |
タノックス インコーポレーテッド |
アレルギー及び喘息治療用Ｆｃε融合タンパク質
|